Compugen (CGEN) Receivables - Net (2009 - 2024)

Compugen's (CGEN) quarterly Receivables - Net came in at $5.0 million in Q2 2024, down 91.8% quarter-over-quarter from $61.0 million in Q4 2023.

Compugen (CGEN) Receivables - Net (2009 - 2024) Analysis & Trends

Compugen has disclosed Receivables - Net across 10 years of filings, most recently posting $5.0 million for Q2 2024.

  • Receivables - Net for Q2 2024 came in at $5.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was $5.0 million (changed N/A YoY), and the FY2023 annual result was $61.0 million, changed N/A from the prior year.
  • Receivables - Net came in at $5.0 million for Q2 2024 at Compugen, down from $61.0 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $61.0 million in Q4 2023 to a low of $2.0 million in Q4 2020.
  • The 4-year median for Receivables - Net is $5.5 million (2021), against an average of $18.5 million.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Compugen 189.59 Mn 97.83 Mn 352,000.00

Historic Data

Download Data
DateValue
Jun 30, 2024 5.00 Mn
Jun 30, 2024 5.00 Mn
Dec 31, 2023 61.00 Mn
Dec 31, 2023 61.00 Mn
Sep 30, 2021 6.00 Mn
Sep 30, 2021 6.00 Mn
Dec 31, 2020 2.00 Mn
Dec 31, 2020 2.00 Mn
Sep 30, 2018 7.80 Mn
Sep 30, 2018 7.80 Mn
Mar 31, 2018 10.00 Mn
Mar 31, 2018 10.00 Mn
Jun 30, 2016 400,000.00
Jun 30, 2016 400,000.00
Dec 31, 2015 7.80 Mn
Dec 31, 2015 7.80 Mn
Jun 30, 2014 1.14 Mn
Jun 30, 2014 1.14 Mn
Dec 31, 2010 21,000.00
Dec 31, 2010 21,000.00